MARK MCDADE

Insider Reports History

Location
Bellevue, WA
Signature
/s/ Brad Middlekauff, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by MARK MCDADE:

Company Role Class Num Shares Value Price $ Report Date Ownership
Icosavax, Inc. Former Director Common Stock 0 $0 $15.29 19 Feb 2024 By Qiming U.S. Healthcare Fund II, L.P.
Icosavax, Inc. Former Director Common Stock 0 $0 $15.29 19 Feb 2024 Direct
Tourmaline Bio, Inc. Director Common Stock 0 $0 $47.83 28 Oct 2025 By Qiming U.S. Healthcare Fund III,L.P.
Tourmaline Bio, Inc. Director Common Stock 0 $0 $47.83 28 Oct 2025 By Qiming U.S. Healthcare Fund II,L.P.
Tourmaline Bio, Inc. Director Common Stock 0 $0 $47.83 28 Oct 2025 By Qiming U.S. Healthcare Fund I,L.P.
Tourmaline Bio, Inc. Director Common Stock 0 $0 $47.83 28 Oct 2025 Direct
Tourmaline Bio, Inc. Director Stock Option (Right to Buy) 16,800 04 Jun 2025 Direct
Icosavax, Inc. Former Director Stock Option (Right to Buy) 0 19 Feb 2024 Direct
Tourmaline Bio, Inc. Director Employee Stock Option (Right to Buy) 0 28 Oct 2025 Direct

Insider Reports Filed by MARK MCDADE

Symbol Company Period Transactions Value $ Form Type Role Filing Time
TRML Tourmaline Bio, Inc. 28 Oct 2025 7 $0 4 Director 28 Oct 2025, 18:30
TRML Tourmaline Bio, Inc. 04 Jun 2025 1 $0 4 Director 06 Jun 2025, 16:30
TRML Tourmaline Bio, Inc. 05 Jun 2024 1 $0 4 Director 07 Jun 2024, 16:03
/report/000095017024017405-mcdade-mark-2024-02-19 Icosavax, Inc. 19 Feb 2024 4 $0 4 Former Director 20 Feb 2024, 19:38
TRML Tourmaline Bio, Inc. 29 Jan 2024 1 +$3,250,000 4 Director 31 Jan 2024, 16:26
TRML Tourmaline Bio, Inc. 19 Oct 2023 4 $0 4 Director 23 Oct 2023, 20:26
TRML Talaris Therapeutics, Inc. 13 Jun 2023 1 $0 4 Director 14 Jun 2023, 18:59
/report/000120919123035589-mcdade-mark-2023-06-06 Icosavax, Inc. 06 Jun 2023 1 $0 4 Director 08 Jun 2023, 20:46
/report/000120919122036659-mcdade-mark-2022-06-10 Icosavax, Inc. 10 Jun 2022 2 $0 4 Director 14 Jun 2022, 16:12
TRML Talaris Therapeutics, Inc. 09 Jun 2022 1 $0 4 Director 13 Jun 2022, 18:20
/report/000120919122022968-mcdade-mark-2022-04-01 Icosavax, Inc. 01 Apr 2022 1 +$299,798 4 Director 05 Apr 2022, 16:10